These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6825138)

  • 1. [Hepatitis B virus and its role in the development of hepatic carcinoma].
    Horejsí J
    Cas Lek Cesk; 1983 Jan; 122(2):33-5. PubMed ID: 6825138
    [No Abstract]   [Full Text] [Related]  

  • 2. [New knowledge of the therapy and prevention of liver diseases. Key points: hepatitis vaccinations--differential diagnosis of hepatitis].
    Eisenburg J
    Fortschr Med; 1985 Jan; 103(1-2):15-9. PubMed ID: 2982708
    [No Abstract]   [Full Text] [Related]  

  • 3. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.
    Realdi G; Alberti A; Rugge M; Bortolotti F; Rigoli AM; Tremolada F; Ruol A
    Gastroenterology; 1980 Aug; 79(2):195-9. PubMed ID: 7399226
    [No Abstract]   [Full Text] [Related]  

  • 4. Does delta infection play a part in the pathogenesis of hepatitis B virus related hepatocellular carcinoma?
    Craxì A; Raimondo G; Pagliaro L
    Br Med J (Clin Res Ed); 1984 Aug; 289(6440):322. PubMed ID: 6331566
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antigenic relationships between hepatitis type B and primary carcinoma of the liver].
    Zhang FS
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Feb; 3(1):49-52. PubMed ID: 6821028
    [No Abstract]   [Full Text] [Related]  

  • 6. Overview of hepatitis B and transplantation in the hepatitis B patient.
    Garcia G; Petrovic LM; Vierling JM
    Semin Liver Dis; 2000; 20 Suppl 1():3-6. PubMed ID: 10895437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum markers of B virus in chronic active hepatitis].
    Segovia E; Rattoni N; Landa L
    Rev Gastroenterol Mex; 1981; 46(1):23-6. PubMed ID: 7280459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients.
    Takano S; Yokosuka O; Imazeki F; Tagawa M; Omata M
    Hepatology; 1995 Mar; 21(3):650-5. PubMed ID: 7875662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of infection by hepatitis B virus in asymptomatic drug addicts].
    Santamaría Jauregui JM; Sadaba Garay CF; Martínez Odriozola P; Amiama Ruíz J; Cisterna Cáncer R
    Med Clin (Barc); 1984 Jan; 82(1):13-5. PubMed ID: 6420625
    [No Abstract]   [Full Text] [Related]  

  • 10. Localization of hepatitis B virus antigens in hepatocellular carcinoma.
    Nazarewicz-de Mezer T; Slusarczyk J; Krawczynski K; Nowoslawski A
    Prog Med Virol; 1981; 27():66-76. PubMed ID: 6262874
    [No Abstract]   [Full Text] [Related]  

  • 11. [Delta agent].
    Mathé G
    Biomed Pharmacother; 1984; 38(1):3-5. PubMed ID: 6466779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frequency and prognostic value of the "e" system in hepatitis B virus infections].
    Onesciuc C; Onesciuc I; Jebeleanu L; Serban I; Gorgan V; Crîstina D; Oprean N; Feticu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1980; 25(2):117-20. PubMed ID: 7423088
    [No Abstract]   [Full Text] [Related]  

  • 13. [Radioimmunoassay of E antigen and anti-E antibody system of hepatitis B virus].
    Novak I; Kselikova M; Urbankova I
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):55-7. PubMed ID: 7088919
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
    Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
    Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between HBeAg/anti-HBe and other hepatitis B virus (HBV) markers in healthy carriers.
    Musca A; Cordova C; Barnaba V; Zaccari C
    Quad Sclavo Diagn; 1981 Sep; 17(3):363-9. PubMed ID: 7343989
    [No Abstract]   [Full Text] [Related]  

  • 16. [Seroepidemiology of virus B hepatitis: the Brazilian experience].
    Gayotto LC
    Rev Paul Med; 1985; 103(5):219-21. PubMed ID: 3832312
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic infection by hepatitis B virus and development of primary carcinoma of the liver].
    Wolpert E
    Rev Gastroenterol Mex; 1987; 52(4):211-5. PubMed ID: 3328267
    [No Abstract]   [Full Text] [Related]  

  • 18. [HBV serologic markers in the chronic alcoholism (author's transl)].
    Todeschini G; Frandi G; Vicari O; Bontempelli M; Cavagnera A
    Quad Sclavo Diagn; 1981 Jun; 17(2):123-9. PubMed ID: 7267976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
    Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
    J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Kiszkis H
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):315-23. PubMed ID: 9017146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.